Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Transenterix Inc (NYSE MKT LLC:TRXC)

0.4703
Delayed Data
As of May 26
 -0.0097 / -2.02%
Today’s Change
0.45
Today|||52-Week Range
2.33
-63.82%
Year-to-Date

Today’s Trading

Previous close0.48
Today’s open0.48
Day’s range0.45 - 0.48
Volume592,907
Average volume (3 months)902,248
Market cap$71.3M
Dividend yield--
Data as of 4:00pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-81.36%
Earnings growth (this year)+5.77%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales96.01
Price/Book0.47

Competitors

 Today’s
change
Today’s
% change
IRMDIRadimed Corp0.000.00%
NVTRNuvectra Corp+0.72+7.14%
ALDXAldeyra Therapeutics...0.000.00%
TTOOT2 Biosystems Inc+0.07+2.22%
Data as of 4:00pm ET, 05/26/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$1.5M
Annual profit (last year)-$120.0M
Net profit margin-7,898.62%

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
President, Chief Executive Officer &
Director
Todd M. Pope
CFO, Principal Accounting Officer &
EVP
Joseph P. Slattery
Corporate headquarters
Morrisville, North Carolina

Forecasts